Of further interest, NSG mice injected intravenously with OCI-AML3 leukemic cells and receiving treatment with NPM1-mutated CAR-T cells showed a significant reduction in leukemia burden, resulting in prolonged survival compared to mice treated with untransduced T cells. The gene discussed is NPM1; the disease is leukemia.